Following on from last year’s successful IMIV MRI Pump-Priming Research Scheme, we are pleased to launch a second round of the scheme to support innovative MRI research projects.
The aim of the scheme is to support projects that will lead to competitive external funding applications for MR imaging studies. Applications will therefore be required to demonstrate a clear plan for progressing preliminary studies to grant applications and larger studies.
- All projects must have a Bournemouth University researcher as lead or co-lead applicant (see application form).
- In Round 2, there will be several application windows rather than a single deadline. Up to 200 hours of scanning time will be awarded in total.
- There is no limit on the number of scanning hours that can be applied for, but projects applying for an award of more than 20 hours may be subject to external peer review. Awards will not cover any additional expenses related to scanning, or other aspects of the project.
- Projects must be deliverable within 12 months, including ethical approvals. Projects with ethical approvals already in place will be prioritised.
The first window for applications is now open, and closes on Friday 7th January 2022. There will be further application windows during the year.
To receive the application form, please email imiv@bournemouth.ac.uk.
IMIV MRI Pump-Priming Research Scheme
Urgent note to those applying to BU Global Visiting Fellowship Scheme Round 3










MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ESRC SWDTP – Applications open for PhD Studentships for September 2026
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease